Lucid Diagnostics Inc.

NASDAQ: LUCD · Real-Time Price · USD
1.01
0.02 (1.64%)
At close: Aug 20, 2025, 1:26 PM

Lucid Diagnostics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-45.53M -52.67M -56.17M -28.08M
Depreciation & Amortization
1.17M 2.5M 1.94M 4K
Stock-Based Compensation
4.53M 6.82M 14.99M 9.6M
Other Working Capital
-4.53M 5.61M 9.17M 1.67M
Other Non-Cash Items
119K 4.85M 653K 10.47M
Deferred Income Tax
n/a n/a n/a -10.47M
Change in Working Capital
-4.43M 5.67M 8.91M 807K
Operating Cash Flow
-44.14M -32.82M -29.68M -17.67M
Capital Expenditures
-646K -221K -908K -862K
Cash Acquisitions
n/a n/a -3.2M n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
-350K n/a n/a n/a
Investing Cash Flow
-646K -221K -4.11M -862K
Debt Repayment
18M 10M n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
451K 551K 804K 2.08M
Financial Cash Flow
48.25M 29.46M 2.61M 72.08M
Net Cash Flow
3.46M -3.58M -31.18M 53.55M
Free Cash Flow
-44.79M -33.04M -30.59M -18.53M